PRTCY

What one share of PureTech Health holds

Pharmaceutical Preparations

PureTech Health plc (the “Parent”) is a public company incorporated, domiciled and registered in the United Kingdom (“UK”). The registered number is 09582467 and the registered address is 13th Floor, One Angel Court, London, EC2R 7HJ, United Kingdom.

PureTech Health’s numbers from its SEC filings, divided by its shares. Results cover the latest fiscal year to 2025-12-31; the balance sheet is as of 2025-12-31.

Per-share figures
Sales$0.19
Profit−$4.56
Capex (buildings and equipment)$0.00
Free cash flow−$3.54
Cash and investments$10.45
Book value$12.91

Per share by fiscal year

YearSalesProfitCapexFree cashDividendsBook value
2018$0.76−$1.60$0.16−$2.83—$6.16
2019$0.34$14.40$0.41−$3.77—$22.84
2021$0.61−$2.11$0.19−$5.72—$20.62
2022$0.55−$1.77$0.08−$6.36—$19.46
2023$0.12−$2.38$0.00−$3.84—$17.07
2024$0.19$2.09$0.00−$5.25—$17.32
2025$0.19−$4.56$0.00−$3.54—$12.91

Common questions about PureTech Health

How much does one share of PureTech Health earn?

Over its latest fiscal year, PureTech Health lost $4.56 for each share on $0.19 of sales.

Does PureTech Health pay a dividend?

PureTech Health didn’t pay a dividend over its latest fiscal year, according to its SEC filings.

What is PureTech Health’s book value per share?

PureTech Health’s book value is $12.91 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of December 31, 2025.

How much cash and debt does each share of PureTech Health have?

Each share of PureTech Health has $10.45 of cash and investments, as of December 31, 2025.

What is PureTech Health’s free cash flow per share?

−$3.54 per share over its latest fiscal year. Free cash flow is the cash left over after spending on buildings and equipment.

Has PureTech Health bought back shares?

PureTech Health’s share count fell about 12% from 2018 to 2025. Through buybacks, each remaining share owns a bigger slice of the company.

From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.